Hutchinson-Gilford Progeria Syndrome: A premature aging disease caused by LMNA gene mutations.
Level 5 - mechanism / opinion, no new human data
Narrative review detailing biological mechanisms and preclinical models without primary human trial data
PubMed 27374873 · doi:10.1016/j.arr.2016.06.007
What was done
This is a narrative review summarizing Hutchinson-Gilford Progeria Syndrome (HGPS) and other laminopathies arising from LMNA gene mutations. It describes the cellular consequences of mutant progerin accumulation and examines preclinical therapeutic strategies tested in vitro and in vivo.
What was found
The abstract reports no numerical findings or quantitative effect sizes. It details that aberrant LMNA splicing generates progerin, leading to nuclear morphology defects, misregulated gene expression, impaired DNA repair, telomere shortening, genomic instability, and reduced cellular proliferation. It also notes progerin expression in normal senescent cells and tissue from elderly individuals.
Why it matters
Synthesizing mechanistic pathways of progerin toxicity helps clarify the pathology of premature childhood aging and highlights cellular processes that may overlap with physiological aging.
Limits
The paper is a narrative review providing no primary clinical trial data, systematic search methodology, quantitative statistical synthesis, or participant counts in the abstract.
Cited by
- supports In children with progeria, an LMNA gene defect causes excess progerin production which degrades telomeres at chromosome ends.